Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Binder

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 12, 2025
Enhancing Martini 3 for protein self-interaction simulationsJonas Binder, Matja Zalar, Martin Huelsmeyer, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 20, 2026
New insights into the intrinsic tryptophan fluorescence emission spectra of IgG antibodies and the impact of protein unfolding and aggregationLennart Brack, Jonas Binder, Irene Gialdini, et al.
Journal of the American Chemical Society|November 26, 2025
From Bits to Bonds: High-Throughput Virtual Screening of Ribonucleic Acid Nanocarriers Using a Combinatorial Approach of Machine Learning and Molecular DynamicsFelix Sieber-Schäfer, Jonas Binder, Tim Münchrath, et al.
Molecular Pharmaceutics|December 17, 2020
Generation of mAb Variants with Less Attractive Self-Interaction but Preserved Target Binding by Well-Directed MutationMartin Domnowski, Ken Lo Presti, Jonas Binder, et al.
Molecular Pharmaceutics|February 19, 2024
Closing the Gap between Experiment and Simulation─A Holistic Study on the Complexation of Small Interfering RNAs with PolyethylenimineJonas Binder, Joshua Winkeljann, Katharina Steinegger, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 12, 2025
Enhancing Martini 3 for protein self-interaction simulationsJonas Binder, Matja Zalar, Martin Huelsmeyer, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 20, 2026
New insights into the intrinsic tryptophan fluorescence emission spectra of IgG antibodies and the impact of protein unfolding and aggregationLennart Brack, Jonas Binder, Irene Gialdini, et al.
Journal of the American Chemical Society|November 26, 2025
From Bits to Bonds: High-Throughput Virtual Screening of Ribonucleic Acid Nanocarriers Using a Combinatorial Approach of Machine Learning and Molecular DynamicsFelix Sieber-Schäfer, Jonas Binder, Tim Münchrath, et al.
Molecular Pharmaceutics|December 17, 2020
Generation of mAb Variants with Less Attractive Self-Interaction but Preserved Target Binding by Well-Directed MutationMartin Domnowski, Ken Lo Presti, Jonas Binder, et al.
Molecular Pharmaceutics|February 19, 2024
Closing the Gap between Experiment and Simulation─A Holistic Study on the Complexation of Small Interfering RNAs with PolyethylenimineJonas Binder, Joshua Winkeljann, Katharina Steinegger, et al.
Pageof 1